What is the equity of Evolus this year?
Evolus has equity of -20.69 M USD this year.
Evolus Equity 2024
Evolus Equity
-20.69 M USD
Ticker
EOLS
ISIN
US30052C1071
WKN
A2JDYX
In 2024, Evolus's equity was -20.69 M USD, a -211.83% increase from the 18.5 M USD equity in the previous year.
Evolus Aktienanalyse
What does Evolus do?
Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Evolus's Equity
Evolus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Evolus's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Evolus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Evolus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Evolus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Evolus Stock
What was the equity of Evolus compared to the previous year?
The equity of Evolus has increased/decreased by -211.83% decreased compared to the previous year.
What impact does a high equity have on investors of Evolus?
A high equity is advantageous for investors of Evolus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Evolus?
A low equity can be a risk for investors of Evolus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Evolus affect the company?
An increase in equity of Evolus can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Evolus affect the company?
A reduction in equity of Evolus can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Evolus?
Some factors that can affect the equity of Evolus include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Evolus so important for investors?
The equity of Evolus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Evolus take to change the equity?
To change equity, Evolus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Evolus pay?
Over the past 12 months, Evolus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evolus is expected to pay a dividend of 0 USD.
What is the dividend yield of Evolus?
The current dividend yield of Evolus is .
When does Evolus pay dividends?
Evolus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Evolus?
Evolus paid dividends every year for the past 0 years.
What is the dividend of Evolus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Evolus located?
Evolus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Evolus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Evolus from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.
When did Evolus pay the last dividend?
The last dividend was paid out on 6/30/2024.
What was the dividend of Evolus in the year 2023?
In the year 2023, Evolus distributed 0 USD as dividends.
In which currency does Evolus pay out the dividend?
The dividends of Evolus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Evolus stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Evolus
Our stock analysis for Evolus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evolus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
